News: Webinars

​Agilex Biolabs   →  News   →  Webinars
09
Apr
Date April 9, 2021
Categories Agilex Biolabs videos, Webinars

Hot topics in Immunoassay Bioanalysis

This webinar examines the hot topics in immunoassay bioanalysis for biotechs navigating the immunogenicity and biomarker requirements for clinical trials. Join the discussion with panelists from Agliex Biolabs, Australia’s largest and most technologically advanced specialist bioanalytical laboratory for clinical trials, and B2S Life Sciences, a biotherapeutic enablement company advancing improved analytical methods and outcomes for developers of biotherapeutic drugs and diagnostics
Read More
Author Agilex Biolabs
22
Aug
Date August 22, 2020
Categories Webinars

Endpoints News Webinar: Why Australia is the World’s Leading Early Phase Destination – plus up to 50% cost savings

Why Australia is the World’s Leading Early Phase Destination – Rapid Start-up, No IND Required, and a Government-Backed Refund on Almost Half of all Trial Costs Increasingly Sponsors are wanting to be actively involved in the core clinical partner selection because they matter to the success of their clinical research.
Read More
Author Agilex Biolabs
20
Aug
Agilex Biolabs
Date August 20, 2020
Categories Transcripts, Webinars

Endpoints Webinar (transcript): Why Australia is the World Leader for Phase 1 Trials

Hi, everyone. I'm Arsalan Arif, the publisher of Endpoints News, and I'm pleased to be your moderator today. Today's webinar is sponsored by Agilex Biolabs in Australia. Our topic is Why Australia is the World's Leading Early Phase Destination - Rapid Start-up, No IND Required, and a Government-Backed Refund on Almost Half of all Trial Costs. I'm joined by two great guests today. Kurt Sales, the Director of Immunoassay at Agilex Biolabs, and Jane Kelly, the CEO of CMAX Clinical Research.
Read More
Author Agilex Biolabs
30
Jul
Date July 30, 2020
Categories Webinars

Endpoints Webinar: How Easy is it to Move Your Trial to Australia?

Gathering together the key clinical service providers for a trial can be a daunting process – especially if you are going off-shore to reactivate trials or start new trials to make up for COVID delays.

However, Australia offers a refreshingly streamlined process because of its group of proven top-tier providers that regularly work together so are fully engaged and in sync with processes and each other’s requirements and capabilities. This makes setting up trials in Australia a smooth, professional, and rapid process for biotechs. This webinar looks at how moving trials to Australia could be much easier than you think.
Read More
Author Agilex Biolabs
30
Jul
Agilex Biolabs
Date July 30, 2020
Categories Transcripts, Webinars

Endpoints Webinar: (Transcript) The Australian Advantage, de-risk your early phase trials

All right. Hi everybody. I’m Arsalan Arif, the publisher of Endpoints News and I’m pleased to be your moderator today. Today’s webinar is sponsored by Agilex Biolabs in Australia and our topic is the Australian Advantage, de-risk your early phase trials. I’m joined by Dr Kurt Sales today with Agilex Biolabs. He’s got an approximately 20 minute presentation and we’re going to follow it up with a quick Q&A. And now I give you Dr Kurt Sales.
Read More
Author Agilex Biolabs
20
May
Agilex Biolabs
Date May 20, 2020
Categories Transcripts, Webinars

Agilex Biolabs Presents at OCT (transcript)

The reality is, Australia has fantastic key opinion leaders, some great principal investigators that have been running clinical trials for decades. The CROs, RFA with FDA and EMA requirements. And in fact, our whole Australian service provision industry sets itself to that standard because ultimately that is the client base that Australia is servicing. Most CROs in Australia and service providers will be able to talk about situations where their data has been presented to the FDA or EMA with success.
Read More
Author Agilex Biolabs
1 2 3